Tandem Diabetes Care
(NASDAQ) TNDM
Tandem Diabetes Care Financials at a Glance
Market Cap
$1.34B
Revenue (TTM)
$1.01B
Net Income (TTM)
$204.71M
EPS (TTM)
$-3.07
P/E Ratio
-6.38
Dividend
$0.00
Beta (Volatility)
1.40 (Average)
Dividend
$0.00
Beta (Volatility)
1.40 (Average)
Price
$19.62
Volume
110,304
Open
$21.20
Price
$19.62
Volume
110,304
Open
$21.20
Previous Close
$19.62
Daily Range
$19.54 - $21.20
52-Week Range
$9.98 - $29.65
Dividend
$0.00
Beta (Volatility)
1.40 (Average)
Price
$19.62
Volume
110,304
Open
$21.20
Previous Close
$19.62
Daily Range
$19.54 - $21.20
52-Week Range
$9.98 - $29.65
TNDM News
TNDM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tandem Diabetes Care
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
2,500
CEO
John F. Sheridan, MBA
Website
www.tandemdiabetes.comHeadquarters
San Diego, CA 92121, US
TNDM Financials
Key Financial Metrics (TTM)
Gross Margin
54%
Operating Margin
-18%
Net Income Margin
-20%
Return on Equity
-98%
Return on Capital
-29%
Return on Assets
-23%
Earnings Yield
-15.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.34B
Shares Outstanding
68.33M
Volume
110.30K
Short Interest
0.00%
Avg. Volume
2.00M
Financials (TTM)
Gross Profit
$530.85M
Operating Income
$78.12M
EBITDA
$174.70M
Operating Cash Flow
$9.72M
Capital Expenditure
$19.95M
Free Cash Flow
$29.67M
Cash & ST Invst.
$292.67M
Total Debt
$444.48M
Tandem Diabetes Care Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$290.38M
+2.7%
Gross Profit
$167.46M
+6.4%
Gross Margin
57.67%
N/A
Market Cap
$1.34B
N/A
Market Cap/Employee
$504.97K
N/A
Employees
2,650
N/A
Net Income
$589.00K
-178.0%
EBITDA
$11.25M
+83.8%
Quarterly Fundamentals
Net Cash
$271.68M
-671.0%
Accounts Receivable
$165.49M
+44.4%
Inventory
$128.77M
-13.9%
Long Term Debt
$539.97M
+30.2%
Short Term Debt
$24.37M
-58.6%
Return on Assets
-23.23%
N/A
Return on Invested Capital
-28.89%
N/A
Free Cash Flow
$3.10M
-59.4%
Operating Cash Flow
$9.79M
-8.7%